Titan Medical (TSX:TMD) CEO David McNally told shareholders today that the company must raise $85 million to finish developing its Sport robot-assisted surgery device and file for FDA clearance. The Toronto-based medical device company is considering raising that money through equity or debt, licensing, merger or acquisition. Titan Medical lost nearly half its value in October […]
Cardica Inc. (NSDQ:CRDC) inked a two-year, $10 million stock purchasing deal with investment firm Aspire Capital Fund LLC.
The agreement calls for Cardica to control the timing and amount of any sales, using a formula based on the price of CRDC stock over the 12 days preceding the sale.